 |
인쇄하기
취소
|
Bukwang files patent application for new clevudine agent
Bukwang has recently filed its patent application for new clevudine combination preparation, with an aim to prevent drug-resistance problem and maximize the therapeutic effects.
New combination product contains clevudine and adefovir dipivoxil.
Bukwang will work to develop this new combination product to contribute to improving the health care of patients.
Clevudine is an antiviral age...
New combination product contains clevudine and adefovir dipivoxil.
Bukwang will work to develop this new combination product to contribute to improving the health care of patients.
Clevudine is an antiviral age...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.